论文部分内容阅读
Graves 眼病是颇棘手的临床问题,可引起复视、视觉缺失、严重眼炎和突眼,目前尚无满意的治疗方法。作者对11例严重 Graves 眼病而甲状腺机能正常的患者应用甲基强的松龙静脉注射治疗,并随访6个月以上,进行眼眶 CT、抗体测定及眼科检查等项目以观察疗效。11例患者(女6、男5),年龄28～60(平均52.6)岁,眼病病程为3～72个月,均无心血管疾病。作者谨慎地采用了较用于移植排斥反应或肾小球肾炎时小的剂量。甲基强的松龙0.5g 加在200ml 等渗盐水
Graves ophthalmopathy is a difficult clinical problem that can cause diplopia, visual loss, severe ophthalmia and exophthalmos. There are currently no satisfactory treatments. The author of 11 cases of severe Graves eye disease and thyroid function in patients with normal use of methylprednisolone intravenous therapy and follow-up of 6 months or more, orbital CT, antibody testing and eye examination and other projects to observe the effect. Eleven patients (6 males and 5 females) aged 28 to 60 years (average 52.6 years) with eye disease course of 3 to 72 months had no cardiovascular disease. The authors cautiously used smaller doses than those used for transplant rejection or glomerulonephritis. Methylprednisolone 0.5g in 200ml isotonic saline